With nearly 25 years of clinical research experience, CROMSOURCE knows the most efficient ways to run a clinical trial. When it comes to trials focused on addressing the COVID-19 global threat, with our broad experience in projects covering vaccines, therapeutic agents and diagnostics, we are proud to support our clients in fighting against this pandemic.
With the day-to-day changes that COVID-19 is bringing to the world in general and healthcare in particular, it is important to stay and remain flexible and agile.
CROMSOURCE is perfectly positioned to provide the flexibility needed and the best support to our clients to be successful in this fight.
Our flexibility is demonstrated by our ability to update methodology and actions based on client needs and/or feedback from health authorities and to work with our clients hand in hand to adapt thought processes and deliverables to achieve outcomes that meet a constantly changing environment.
We have a dedicated COVID-19 Expert Team guiding our clients to navigate this challenging and changing landscape. According to our motto, “Advise. Agree. Deliver”, we advise and agree with our clients the best regulatory and operational strategies and provide guidance on start-up, monitoring strategies, patient safety, and biometrics support.
Even as the regulatory landscape changes often and recruitment and the management of projects can be more challenging during the pandemic, our experience gives us an advantage to overcome all these to find solutions quickly.
We have great relationships with regulatory bodies and sites, making us able to get trials up-and-running quickly, to begin finding the life-changing therapies that the world needs to fight COVID-19.
Diagnostics – Vaccines - Therapeutics
Based on our broad expertise combined with our cutting-edge technological support, we are able to help our clients fight this pandemic from different angles by being involved in the research of vaccines, diagnostics and therapeutic agents. Ongoing projects managed by our COVID-19 Expert Teams cover all the three different areas of expertise and are involving specialized sites all over Europe and US.
Side-by-side with our Clients we are at the forefront of the fight against COVID-19!
Rapid study start-up is of paramount importance when developing products for the treatment of COVID-19 patients. For one of our Clients, we have been able to achieve a very important milestone by getting their sites up ready in record time. Due to our knowledge and relationship with hundreds of sites in the United States, we have been able to select the right ones and to activate seven of their nine sites within five days of the client agreement.
Their response to reaching this milestone quickly and efficiently was this positive message:
“I wanted to thank you for the great work you have done since we awarded the project. The progress on site activation is unprecedented, you have brought up 7 sites in a matter of days, and the level of responsiveness and diligence of the entire team has been on point. On behalf of our entire team a big Thank you! We can’t wait to see the results on enrolment and positives next week.”
This pandemic crisis calls for urgency for COVID-19 trials. Contact us to discuss how we are taking appropriate steps to accelerate these types of trials to help sponsors get diagnostics, vaccines and life-saving drugs to market efficiently and quickly. We look forward to fighting in this pandemic with you!
CROMSOURCE is an ISO-certified, international contract research organization providing a comprehensive portfolio of services to the pharmaceutical, biotechnology, and medical device industries. Specializing in clinical development and staffing solutions, we offer a flexible approach to ensure our clients’ unique needs are supported. CROMSOURCE is unparalleled in offering an End-to-End Guarantee covering trial timelines, enrolment, and price. CROMSOURCE operates offices across all regions of Europe and North America.Supporting the fight against COVID19
|CROMSOURCE Supporting the fight against COVID19 Fact sheet.pdf||Download|